Who Paid My Doc
Evarrest
Biological Biosurgical
NDC 63713-050-24
General payments
$1,415,086
Research payments
$108,243
Through program year 2025, $1,415,086 in general payments and $108,243 in research payments were reported against Evarrest (Biosurgical).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $587,060 | 2,593 |
| 2024 | General | $291,421 | 1,351 |
| 2024 | Research | $1,700 | 2 |
| 2023 | General | $253,768 | 893 |
| 2023 | Research | $4,816 | 8 |
| 2022 | General | $84,105 | 919 |
| 2022 | Research | $15,453 | 5 |
| 2021 | General | $38,831 | 52 |
| 2021 | Research | $29,776 | 20 |
| 2020 | General | $56,896 | 40 |
| 2020 | Research | $56,497 | 18 |
| 2019 | General | $103,004 | 36 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 84 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,884 general · 53 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.